Travere Therapeutics Inc (TVTX)

Total Costs & Expenses

$165.63M

Quarterly · Period ending: · USD

TVTX logo

TVTX Total Costs & Expenses

Latest reported$165.63M
TVTX Quarterly Total Costs & Expenses ($3.38K → $165.63M)
High-resolution chart · PNG

TVTX total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Travere Therapeutics Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
165,630,000
164,114,000
162,117,000
139,928,000
127,099,000
124,406,000
135,524,000
119,047,000
121,167,000
180,352,000
127,898,000
129,680,000
136,147,000
137,283,000
122,719,000
110,679,000
119,618,000
105,537,000
104,439,000
99,928,000
89,932,000
94,956,000
169,534,000
70,574,000
71,541,000
62,836,000
65,623,999
63,810,000
77,883,000
67,129,000
59,553,000
59,688,000
60,738,000
52,717,000
48,025,000
45,387,000
49,114,000
44,684,000
47,906,000
49,061,000
41,901,000
34,554,000
38,899,000
36,885,000
30,892,000
25,476,243
32,993,671
31,792,122
26,245,457
16,979,648
11,467,199
5,154,486
5,099,902
2,250,484
3,161
3,000
3,009
3,758
3,018
3,525
3,024
3,580
3,091
6,626
6,644
10,105
6,644
6,694
7,645
4,251
3,050
3,376
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.